Study S003254

A Randomized, Double-blind, Placebo-controlled, Multiple-dose, Phase II Study to Evaluate the Efficacy and Safety of 3 Months of Twice-a-week Injections of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus on Metformin Monotherapy

ClinicalTrials.gov record

Registration

Registration: NCT00674466
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: QUADRUPLE
Status: COMPLETED
Enrollment: 90
Start: 2008-03
Primary completion: 2008-11
Lead sponsor: ConjuChem
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:1.5 mg or 2.0 mg CJC-1134-PC; DRUG:Placebo
Results posted: TRUE

Registered primary outcomes

Reduction of HbA1c From Baseline [Screening and Day 85]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.